{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T12:53:55Z","timestamp":1794920035435,"version":"4.9.1"},"reference-count":156,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Secretar\u00eda de Ciencia, Humanidades, Tecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["1138096"],"award-info":[{"award-number":["1138096"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Tropica"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.actatropica.2025.107940","type":"journal-article","created":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T06:31:41Z","timestamp":1765089101000},"page":"107940","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Mechanisms of resistance of Trypanosoma cruzi to benznidazole and nifurtimox: Molecular implications and multifaceted impact"],"prefix":"10.1016","volume":"273","author":[{"given":"Paulina","family":"Ochoa-Mart\u00ednez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"L\u00f3pez-Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aracely","family":"L\u00f3pez-Monteon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeca Georgina","family":"Manning-Cela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3896-7447","authenticated-orcid":false,"given":"Angel","family":"Ramos-Ligonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.actatropica.2025.107940_bib0001","doi-asserted-by":"crossref","first-page":"e2279","DOI":"10.1371\/journal.pntd.0002279","article-title":"Oxidative stress and DNA lesions: the role of 8-oxoguanine lesions in Trypanosoma cruzi cell viability","volume":"7","author":"Aguiar","year":"2013","journal-title":"PLoS. Negl. Trop. Dis."},{"issue":"5","key":"10.1016\/j.actatropica.2025.107940_bib0002","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0013052","article-title":"(In)coherence between Chagas disease policy and the experiences of those affected in Mexico: the need for a transdisciplinary approach","volume":"19","author":"Ak\u00e9-Chan","year":"2025","journal-title":"PLoS. Negl. Trop. Dis."},{"issue":"3","key":"10.1016\/j.actatropica.2025.107940_bib0003","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00281-020-00796-y","article-title":"Implications of asymptomatic infection for the natural history of selected parasitic tropical diseases","volume":"42","author":"Alvar","year":"2020","journal-title":"Semin. Immunopathol."},{"issue":"6","key":"10.1016\/j.actatropica.2025.107940_bib0004","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/emermed-2020-209567","article-title":"Population, intervention, Comparison, outcomes and Study (PICOS) design as a framework to formulate eligibility criteria in systematic reviews","volume":"37","author":"Amir-Behghadami","year":"2020","journal-title":"Emerg. Med. J."},{"issue":"6","key":"10.1016\/j.actatropica.2025.107940_bib0005","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1021\/pr700659m","article-title":"Proteomic analysis of Trypanosoma cruzi resistance to Benznidazole","volume":"7","author":"Andrade","year":"2008","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.actatropica.2025.107940_bib0006","article-title":"Economic burden of Chagas disease in Brazil: a nationwide cost-of-illness study","volume":"50","author":"Andrade","year":"2025","journal-title":"Lancet Reg. Health Am."},{"key":"10.1016\/j.actatropica.2025.107940_bib0007","series-title":"American Trypanosomiasis Chagas Disease: One Hundred Years of Research Editors: Jenny Telleria, Michel Tibayrenc,","article-title":"Treatment of Chagas disease","author":"Apt","year":"2017"},{"issue":"11","key":"10.1016\/j.actatropica.2025.107940_bib158","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0013619","article-title":"Long-term outcomes of benznidazole treatment in chronic Chagas disease: a 27-year cohort study of parasitological cure and death in the Jequitinhonha Valley, Brazil","volume":"19","author":"Assis","year":"2025","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2025.107940_bib0008","doi-asserted-by":"crossref","DOI":"10.1590\/0074-02760210151","article-title":"Van der Laat C. Population movements, borders, and Chagas disease","volume":"117","author":"Avaria","year":"2022","journal-title":"Mem. Inst. Oswaldo Cruz."},{"issue":"3","key":"10.1016\/j.actatropica.2025.107940_bib0009","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.bbrc.2004.07.002","article-title":"Post genomic analysis of permeases from the amino acid\/auxin family in protozoan parasites","volume":"321","author":"Bouvier","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.actatropica.2025.107940_bib0010","first-page":"S71","article-title":"alud [Chagas disease in the Americas: an ecohealth perspective]","volume":"25","author":"Brice\u00f1o-Le\u00f3n","year":"2009"},{"key":"10.1016\/j.actatropica.2025.107940_bib159","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1146\/annurev-animal-013120-043949","article-title":"Chagas Disease Ecology in the United States: recent advances in understanding Trypanosoma cruzi transmission among triatomines, wildlife, and domestic animals and a quantitative synthesis of vector-host interactions","volume":"10","author":"Busselman","year":"2022","journal-title":"Annu. Rev. Anim. Biosci."},{"issue":"567","key":"10.1016\/j.actatropica.2025.107940_bib0011","doi-asserted-by":"crossref","first-page":"eabb7656","DOI":"10.1126\/scitranslmed.abb7656","article-title":"A modified drug regimen clears active and dormant trypanosomes in mouse models of Chagas disease","volume":"12","author":"Bustamante","year":"2020","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.actatropica.2025.107940_bib0012","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1586\/17512433.2014.909282","article-title":"Potential new clinical therapies for Chagas disease","volume":"7","author":"Bustamante","year":"2014","journal-title":"Expert. Rev. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.actatropica.2025.107940_bib0013","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1128\/AAC.32.2.241","article-title":"Differences in resistance to reinfection with low and high inocula of Trypanosoma cruzi in chagasic mice treated with nifurtimox and relation to immune response","volume":"32","author":"Cabeza Meckert","year":"1988","journal-title":"Antimicrob. Agents Chemother"},{"issue":"2","key":"10.1016\/j.actatropica.2025.107940_bib0014","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3390\/pathogens14020106","article-title":"Understanding host-pathogen interactions in congenital Chagas disease through transcriptomic approaches","volume":"14","author":"C\u00e1ceres","year":"2025","journal-title":"Pathogens."},{"issue":"12","key":"10.1016\/j.actatropica.2025.107940_bib0015","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1017\/S0031182014000882","article-title":"Therapeutic responses to different anti-trypanosoma cruzi drugs in experimental infection by benznidazole-resistant parasite stock","volume":"141","author":"Caldas","year":"2014","journal-title":"Parasitology."},{"issue":"6","key":"10.1016\/j.actatropica.2025.107940_bib0016","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1007\/s00436-013-3398-z","article-title":"P-glycoprotein efflux pump plays an important role in Trypanosoma cruzi drug resistance","volume":"112","author":"Campos","year":"2013","journal-title":"Parasitol. Res."},{"issue":"1","key":"10.1016\/j.actatropica.2025.107940_bib0017","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.molbiopara.2014.01.002","article-title":"Benznidazole-resistance in Trypanosoma cruzi: evidence that distinct mechanisms can act in concert","volume":"193","author":"Campos","year":"2014","journal-title":"Mol. Biochem. Parasitol."},{"issue":"1","key":"10.1016\/j.actatropica.2025.107940_bib0018","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-14986-6","article-title":"Genome-wide mutagenesis and multi-drug resistance in American trypanosomes induced by the front-line drug benznidazole","volume":"7","author":"Campos","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.actatropica.2025.107940_bib0019","series-title":"Development Research Working Paper Series","author":"Cardona","year":"2013"},{"issue":"5","key":"10.1016\/j.actatropica.2025.107940_bib0020","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-011181","article-title":"Longitudinal study of patients with chronic Chagas cardiomyopathy in Brazil (SaMi-Trop project): a cohort profile","volume":"6","author":"Cardoso","year":"2016","journal-title":"BMJ Open."},{"issue":"5","key":"10.1016\/j.actatropica.2025.107940_bib0021","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1550-7408.2003.tb00141.x","article-title":"Lack of arginine decarboxylase in Trypanosoma cruzi epimastigotes","volume":"50","author":"Carrillo","year":"2003","journal-title":"J. Eukaryot. Microbiol."},{"issue":"6","key":"10.1016\/j.actatropica.2025.107940_bib0022","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1093\/jac\/dkab054","article-title":"Reduced Trypanosoma cruzi-specific humoral response and enhanced T cell immunity after treatment interruption with benznidazole in chronic Chagas disease","volume":"76","author":"Castro Eiro","year":"2021","journal-title":"J. Antimicrob. Chemother"},{"issue":"8","key":"10.1016\/j.actatropica.2025.107940_bib0023","doi-asserted-by":"crossref","first-page":"847","DOI":"10.2217\/fmb.11.74","article-title":"Antiparasitic prodrug nifurtimox: revisiting its activation mechanism","volume":"6","author":"Cerecetto","year":"2011","journal-title":"Future Microbiol."},{"issue":"4","key":"10.1016\/j.actatropica.2025.107940_bib0024","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1542\/pir.2022-005857","article-title":"Congenital Chagas disease","volume":"44","author":"Chancey","year":"2023","journal-title":"Pediatr. Rev."},{"key":"10.1016\/j.actatropica.2025.107940_bib0025","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.actatropica.2016.01.002","article-title":"A global systematic review of Chagas disease prevalence among migrants","volume":"156","author":"Conners","year":"2016","journal-title":"Acta Trop."},{"key":"10.1016\/j.actatropica.2025.107940_bib0026","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.760830","article-title":"Trypanosoma cruzi Genomic variability: array comparative genomic hybridization analysis of clone and parental strain","volume":"12","author":"Cortez","year":"2022","journal-title":"Front. Cell Infect. Microbiol."},{"key":"10.1016\/j.actatropica.2025.107940_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(25)00562-6","article-title":"Global, regional, and national burden of Chagas disease, 1990\u20132023: a systematic analysis for the Global Burden of Disease Study 2023","author":"Cousin","year":"2025","journal-title":"Lancet Infect. Dis."},{"issue":"5","key":"10.1016\/j.actatropica.2025.107940_bib0028","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010386","article-title":"Use of benznidazole to treat chronic Chagas disease: an updated systematic review with a meta-analysis","volume":"16","author":"Crespillo-And\u00fajar","year":"2022","journal-title":"PLoS. Negl. Trop. Dis."},{"issue":"1","key":"10.1016\/j.actatropica.2025.107940_bib0029","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1186\/s13071-024-06445-9","article-title":"Exploring Trypanosoma cruzi transmission dynamics in an acute Chagas disease outbreak using next-generation sequencing","volume":"17","author":"Cruz-Saavedra","year":"2024","journal-title":"Parasit. Vectors."},{"key":"10.1016\/j.actatropica.2025.107940_bib0030","article-title":"The epidemiology of Chagas disease in the Americas","volume":"37","author":"Cucunub\u00e1","year":"2024","journal-title":"Lancet Reg. Health Am."},{"issue":"12","key":"10.1016\/j.actatropica.2025.107940_bib0032","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.3390\/molecules26123510","article-title":"Intrinsic and chemotherapeutic stressors modulate ABCC-like transport in Trypanosoma cruzi","volume":"26","author":"da Costa","year":"2021","journal-title":"Molecules."},{"key":"10.1016\/j.actatropica.2025.107940_bib0033","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3389\/fmicb.2018.00205","article-title":"Functional characterization of ABCC proteins from Trypanosoma cruzi and their involvement with thiol transport","volume":"9","author":"da Costa","year":"2018","journal-title":"Front. Microbiol."},{"issue":"2","key":"10.1016\/j.actatropica.2025.107940_bib0034","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3390\/pathogens14020133","article-title":"Trypanosoma cruzi transmission through blood samples and derivatives: main routes, control strategies, and recent advancements in blood banks","volume":"14","author":"da Gama","year":"2025","journal-title":"Pathogens."},{"issue":"1","key":"10.1016\/j.actatropica.2025.107940_bib0036","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12917-025-04486-5","article-title":"Chagas disease in a naturally-infected dog from Northeast Brazil: a case report","volume":"21","author":"deAra\u00fajo-Neto","year":"2025","journal-title":"BMC. Vet. Res."},{"key":"10.1016\/j.actatropica.2025.107940_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2025.107673","article-title":"Serum nitric oxide in chronic Chagas disease: a scoping review","volume":"267","author":"de Oliveira","year":"2025","journal-title":"Acta Trop."},{"issue":"10422","key":"10.1016\/j.actatropica.2025.107940_bib0038","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(23)01787-7","article-title":"Chagas disease","volume":"403","author":"de Sousa","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.actatropica.2025.107940_bib0039","doi-asserted-by":"crossref","DOI":"10.4269\/ajtmh.24-0516","article-title":"Knowledge, attitudes, and practices toward Chagas Disease: a cross-sectional survey of Bolivians in the Gran Chaco and Latin American migrants in London","author":"Del Carmen D\u00edez Hern\u00e1ndez","year":"2025","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"1\u20132","key":"10.1016\/j.actatropica.2025.107940_bib0040","article-title":"Trypanosoma cruzi amastigote transcriptome analysis reveals heterogenous populations with replicating and dormant parasites","volume":"26","author":"Desale","year":"2024","journal-title":"Microbes. Infect."},{"issue":"Suppl 1","key":"10.1016\/j.actatropica.2025.107940_bib0035","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1590\/S0102-311X2007001300003","article-title":"Globaliza\u00e7\u00e3o, iniq\u00fcidade e doen\u00e7a de Chagas [Globalization, inequity and Chagas disease]","volume":"23","author":"Dias","year":"2007","journal-title":"Cad. Saude Publica"},{"issue":"2","key":"10.1016\/j.actatropica.2025.107940_bib0041","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1590\/S0037-86822008000200012","article-title":"Problems and perspectives for Chagas disease control: in search of a realistic analysis","volume":"41","author":"Dias","year":"2008","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.actatropica.2025.107940_bib0042","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.773410","article-title":"Mitochondrial sirtuin TcSir2rp3 affects TcSODA activity and oxidative stress response in Trypanosoma cruzi","volume":"11","author":"Dos Santos Moura","year":"2021","journal-title":"Front. Cell Infect. Microbiol."},{"issue":"5","key":"10.1016\/j.actatropica.2025.107940_bib0043","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0035-9203(87)90020-4","article-title":"Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease","volume":"81","author":"Filardi","year":"1987","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.actatropica.2025.107940_bib0044","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.meegid.2015.01.030","article-title":"ABCG-like transporter of Trypanosoma cruzi involved in benznidazole resistance: gene polymorphisms disclose inter-strain intragenic recombination in hybrid isolates","volume":"31","author":"Franco","year":"2015","journal-title":"Infect. Genet. Evol."},{"issue":"5","key":"10.1016\/j.actatropica.2025.107940_bib0045","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1128\/AAC.02185-15","article-title":"Putative role of the Aldo-Keto reductase from Trypanosoma cruzi in Benznidazole Metabolism","volume":"60","author":"Garavaglia","year":"2016","journal-title":"Antimicrob. Agents Chemother"},{"issue":"7","key":"10.1016\/j.actatropica.2025.107940_bib0046","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1002\/jcb.25978","article-title":"Transcriptome and functional genomics reveal the participation of adenine phosphoribosyltransferase in Trypanosoma cruzi resistance to Benznidazole","volume":"118","author":"Garc\u00eda-Huertas","year":"2017","journal-title":"J. Cell Biochem."},{"issue":"9","key":"10.1016\/j.actatropica.2025.107940_bib0047","doi-asserted-by":"crossref","DOI":"10.1098\/rsos.170773","article-title":"Prostaglandin F2\u03b1 synthase in Trypanosoma cruzi plays critical roles in oxidative stress and susceptibility to benznidazole","volume":"4","author":"Garc\u00eda-Huertas","year":"2017","journal-title":"R. Soc. Open. Sci."},{"key":"10.1016\/j.actatropica.2025.107940_bib157","article-title":"Global, regional, and national burden of Chagas disease, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023","year":"2025","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.actatropica.2025.107940_bib0048","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2024.1439714","article-title":"The expression of immune response genes in patients with chronic Chagas disease is shifted toward the levels observed in healthy subjects as a result of treatment with Benznidazole","volume":"14","author":"G\u00f3mez","year":"2024","journal-title":"Front. Cell Infect. Microbiol."},{"issue":"1","key":"10.1016\/j.actatropica.2025.107940_bib0049","doi-asserted-by":"crossref","first-page":"59","DOI":"10.5334\/gh.1150","article-title":"Global, regional, and national trends of Chagas Disease from 1990 to 2019: comprehensive analysis of the Global burden of disease study","volume":"17","author":"G\u00f3mez-Ochoa","year":"2022","journal-title":"Glob. Heart."},{"issue":"5","key":"10.1016\/j.actatropica.2025.107940_bib0050","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/mmi.13830","article-title":"Aldo-keto reductase and alcohol dehydrogenase contribute to benznidazole natural resistance in Trypanosoma cruzi","volume":"106","author":"Gonz\u00e1lez","year":"2017","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.actatropica.2025.107940_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101231","article-title":"Gamma-glutamylcysteine synthetase and tryparedoxin 1 exert high control on the antioxidant system in Trypanosoma cruzi contributing to drug resistance and infectivity","volume":"26","author":"Gonz\u00e1lez-Ch\u00e1vez","year":"2019","journal-title":"Redox. Biol."},{"issue":"15","key":"10.1016\/j.actatropica.2025.107940_bib0052","doi-asserted-by":"crossref","first-page":"13088","DOI":"10.1074\/jbc.M111.230847","article-title":"Nifurtimox activation by trypanosomal type I nitroreductases generates cytotoxic nitrile metabolites","volume":"286","author":"Hall","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.actatropica.2025.107940_bib0053","article-title":"Molecular diagnosis of chagas disease in Colombia: parasitic loads and discrete typing units in patients from acute and chronic phases","volume":"10","author":"Hernandez","year":"2016","journal-title":"PLoS. Negl. Trop. Dis."},{"issue":"2","key":"10.1016\/j.actatropica.2025.107940_bib0054","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3390\/pathogens14020183","article-title":"Fighting strategies against Chagas' Disease: a review","volume":"14","author":"Hern\u00e1ndez-Flores","year":"2025","journal-title":"Pathogens."},{"issue":"1","key":"10.1016\/j.actatropica.2025.107940_bib0055","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3390\/pathogens14010061","article-title":"Trypanosoma cruzi: genomic diversity and structure","volume":"14","author":"Herreros-Cabello","year":"2025","journal-title":"Pathogens."},{"issue":"1","key":"10.1016\/j.actatropica.2025.107940_bib0056","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3390\/tropicalmed6010023","article-title":"New contributions to the elimination of Chagas disease as a public health problem: towards the sustainable development goals by 2030","volume":"6","author":"Heukelbach","year":"2021","journal-title":"Trop. Med. Infect. Dis."},{"issue":"7137","key":"10.1016\/j.actatropica.2025.107940_bib0057","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nature05630","article-title":"Multiple molecular mechanisms for multidrug resistance transporters","volume":"446","author":"Higgins","year":"2007","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.actatropica.2025.107940_bib0058","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1248\/yakushi.15-00233-5","article-title":"Industry, academia and government partnership through the Global Health Innovative Technology Fund (GHIT)]","volume":"136","author":"Hinoshita","year":"2016","journal-title":"Yakugaku Zasshi"},{"key":"10.1016\/j.actatropica.2025.107940_bib0059","doi-asserted-by":"crossref","first-page":"i53","DOI":"10.1093\/inthealth\/ihv071","article-title":"Social stigma towards neglected tropical diseases: a systematic review","volume":"1","author":"Hofstraat","year":"2016","journal-title":"Int. Health"},{"issue":"11","key":"10.1016\/j.actatropica.2025.107940_bib0060","doi-asserted-by":"crossref","DOI":"10.1590\/0074-02760180271","article-title":"The \u03b2-blocker carvedilol and the benznidazole modulate the cardiac immune response in the acute infection induced by Colombian strain of the Trypanosoma cruzi","volume":"113","author":"Horta","year":"2018","journal-title":"Mem. Inst. Oswaldo Cruz."},{"issue":"1","key":"10.1016\/j.actatropica.2025.107940_bib0061","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1186\/s13071-016-1918-2","article-title":"Geographical, landscape and host associations of Trypanosoma cruzi DTUs and lineages","volume":"9","author":"Izeta-Alberdi","year":"2016","journal-title":"Parasit. Vectors."},{"issue":"4","key":"10.1016\/j.actatropica.2025.107940_bib0062","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1007\/s11686-022-00608-3","article-title":"Molecular characterization of four Mexican isolates of trypanosoma cruzi and their profile susceptibility to Nifurtimox","volume":"67","author":"Jaime","year":"2022","journal-title":"Acta Parasitol."},{"issue":"4","key":"10.1016\/j.actatropica.2025.107940_bib0063","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/DCC.0000000000000590","article-title":"Chagas Disease cardiomyopathy","volume":"42","author":"Jimenez","year":"2023","journal-title":"Dimens. Crit. Care Nurs."},{"key":"10.1016\/j.actatropica.2025.107940_bib0064","doi-asserted-by":"crossref","DOI":"10.1590\/0074-02760200501","article-title":"The translational challenge in Chagas disease drug development","volume":"117","author":"Kratz","year":"2022","journal-title":"Mem. Inst. Oswaldo Cruz."},{"key":"10.1016\/j.actatropica.2025.107940_bib0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2019.105107","article-title":"Drug discovery for chagas disease: a viewpoint","volume":"198","author":"Kratz","year":"2019","journal-title":"Acta Trop."},{"issue":"9","key":"10.1016\/j.actatropica.2025.107940_bib0066","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1084\/jem.20020885","article-title":"A key role for old yellow enzyme in the metabolism of drugs by Trypanosoma cruzi","volume":"196","author":"Kubata","year":"2002","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.actatropica.2025.107940_bib0067","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/bcp.14700","article-title":"Review of pharmacological options for the treatment of Chagas disease","volume":"88","author":"Lascano","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"10","key":"10.1016\/j.actatropica.2025.107940_bib0068","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1080\/14728222.2023.2264512","article-title":"Molecular targets for Chagas disease: validation, challenges and lead compounds for widely exploited targets","volume":"27","author":"Laureano de Souza","year":"2023","journal-title":"Expert. Opin. Ther. Targets."},{"issue":"4","key":"10.1016\/j.actatropica.2025.107940_bib0069","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S1473-3099(13)70002-1","article-title":"Global economic burden of Chagas disease: a computational simulation model","volume":"13","author":"Lee","year":"2013","journal-title":"Lancet Infect. Dis."},{"issue":"3","key":"10.1016\/j.actatropica.2025.107940_bib0070","first-page":"469","article-title":"Nifurtimox-induced alterations in the cell-mediated immune response to PPD tin guinea-pigs","volume":"30","author":"Lelchuk","year":"1977","journal-title":"Clin. Exp. Immunol."},{"issue":"3","key":"10.1016\/j.actatropica.2025.107940_bib0071","first-page":"434","article-title":"Cell-mediated immunity in Chagas' disease: alterations induced by treatment with a trypanocidal drug (nifurtimox)","volume":"30","author":"Lelchuk","year":"1977","journal-title":"Clin. Exp. Immunol."},{"issue":"10","key":"10.1016\/j.actatropica.2025.107940_bib0072","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1128\/EC.00152-06","article-title":"Modulation of Leishmania ABC protein gene expression through life stages and among drug-resistant parasites","volume":"5","author":"Leprohon","year":"2006","journal-title":"Eukaryot. Cell"},{"issue":"6","key":"10.1016\/j.actatropica.2025.107940_bib0073","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1080\/01459740.2021.1946805","article-title":"Chagas disease across contexts: scientific knowledge in a globalized world","volume":"40","author":"Levin","year":"2021","journal-title":"Med. Anthropol."},{"key":"10.1016\/j.actatropica.2025.107940_bib0074","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3389\/fpubh.2019.00166","article-title":"Chagas Disease: from discovery to a worldwide health problem","volume":"7","author":"Lidani","year":"2019","journal-title":"Front. Public Health"},{"issue":"1","key":"10.1016\/j.actatropica.2025.107940_bib0075","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s13071-023-05775-4","article-title":"Transcriptomic analysis of benznidazole-resistant and susceptible Trypanosoma cruzi populations","volume":"16","author":"Lima","year":"2023","journal-title":"Parasit. Vectors."},{"issue":"5","key":"10.1016\/j.actatropica.2025.107940_bib0076","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11686-025-01125-9","article-title":"Analysis of the behavior of Trypanosoma cruzi in culture against different dosage forms of benznidazole: experimental insights","volume":"70","author":"L\u00f3pez-Dom\u00ednguez","year":"2025","journal-title":"Acta Parasitol."},{"issue":"9","key":"10.1016\/j.actatropica.2025.107940_bib0077","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/tmi.13915","article-title":"Oral transmission of Chagas disease from a one Health approach: a systematic review","volume":"28","author":"L\u00f3pez-Garc\u00eda","year":"2023","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.actatropica.2025.107940_bib0078","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2025.107764","article-title":"Metal-organic frameworks (MOFs): redefining antiparasitic drug delivery","volume":"269","author":"L\u00f3pez-Monteon","year":"2025","journal-title":"Acta Trop."},{"issue":"9","key":"10.1016\/j.actatropica.2025.107940_bib0079","doi-asserted-by":"crossref","first-page":"e711","DOI":"10.1016\/S2666-5247(21)00265-2","article-title":"Pathogen diversity, immunity, and the fate of infections: lessons learned from Trypanosoma cruzi human-host interactions","volume":"3","author":"Magalh\u00e3es","year":"2022","journal-title":"Lancet Microbe"},{"issue":"3","key":"10.1016\/j.actatropica.2025.107940_bib0080","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1089\/vbz.2012.1072","article-title":"Microsatellite and mini-exon analysis of Mexican human DTU I Trypanosoma cruzi strains and their susceptibility to nifurtimox and benznidazole","volume":"13","author":"Mart\u00ednez","year":"2013","journal-title":"Vector. Borne Zoonotic. Dis."},{"issue":"4","key":"10.1016\/j.actatropica.2025.107940_bib0081","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.cbpa.2006.03.004","article-title":"Mode of action of natural and synthetic drugs against Trypanosoma cruzi and their interaction with the mammalian host","volume":"146","author":"Maya","year":"2007","journal-title":"Comp. Biochem. Physiol. a Mol. Integr. Physiol."},{"issue":"2","key":"10.1016\/j.actatropica.2025.107940_bib0082","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/infdis\/jis331","article-title":"Benznidazole resistance in Trypanosoma cruzi is a readily acquired trait that can arise independently in a single population","volume":"206","author":"Mejia","year":"2012","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.actatropica.2025.107940_bib0083","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/1756-3305-4-169","article-title":"Gene expression study using real-time PCR identifies an NTR gene as a major marker of resistance to benzonidazole in Trypanosoma cruzi","volume":"4","author":"Mej\u00eda-Jaramillo","year":"2011","journal-title":"Parasit. Vectors."},{"issue":"2","key":"10.1016\/j.actatropica.2025.107940_bib0084","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0314189","article-title":"Transcriptomic analysis of benznidazole-resistant Trypanosoma cruzi clone reveals nitroreductase I-independent resistance mechanisms","volume":"20","author":"Mej\u00eda-Jaramillo","year":"2025","journal-title":"PLoS. One"},{"key":"10.1016\/j.actatropica.2025.107940_bib0085","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.freeradbiomed.2018.10.436","article-title":"Trypanothione synthetase confers growth, survival advantage and resistance to anti-protozoal drugs in Trypanosoma cruzi","volume":"130","author":"Mes\u00edas","year":"2019","journal-title":"Free Radic. Biol. Med."},{"issue":"3","key":"10.1016\/j.actatropica.2025.107940_bib0086","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s40506-018-0170-z","article-title":"Treatment of Chagas Disease in the United States","volume":"10","author":"Meymandi","year":"2018","journal-title":"Curr. Treat. Options. Infect. Dis."},{"issue":"11","key":"10.1016\/j.actatropica.2025.107940_bib0087","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.amjmed.2020.05.022","article-title":"Chagas Disease: epidemiology and barriers to treatment","volume":"133","author":"Mills","year":"2020","journal-title":"Am. J. Med."},{"key":"10.1016\/j.actatropica.2025.107940_bib0088","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/295034","article-title":"Barriers to testing and treatment for Chagas disease among Latino immigrants in Georgia","volume":"2012","author":"Minneman","year":"2012","journal-title":"J. Parasitol. Res."},{"issue":"7","key":"10.1016\/j.actatropica.2025.107940_bib0089","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS. Med."},{"key":"10.1016\/j.actatropica.2025.107940_bib0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2020.104329","article-title":"Potential association of trypanosoma cruzi DTUs TcV and TcVI with the digestive form of Chagas disease","volume":"84","author":"Monje-Rumi","year":"2020","journal-title":"Infect. Genet. Evol."},{"issue":"1","key":"10.1016\/j.actatropica.2025.107940_bib0091","first-page":"115","article-title":"Trypanocidal effect of nano MOFs-EP on circulating forms of trypanosoma cruzi","volume":"15","author":"Morales-Baez","year":"2020","journal-title":"Iran. J. Parasitol."},{"issue":"3","key":"10.1016\/j.actatropica.2025.107940_bib0092","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1021\/acsinfecdis.2c00569","article-title":"Genetic characterization of Trypanosoma cruzi I populations from an oral Chagas disease outbreak in Venezuela: natural resistance to nitroheterocyclic drugs","volume":"9","author":"Mu\u00f1oz-Calder\u00f3n","year":"2023","journal-title":"ACS. Infect. Dis."},{"issue":"1","key":"10.1016\/j.actatropica.2025.107940_bib0093","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10741-010-9211-5","article-title":"Chronic Chagas' heart disease: a disease on its way to becoming a worldwide health problem: epidemiology, etiopathology, treatment, pathogenesis and laboratory medicine","volume":"17","author":"Mu\u00f1oz-Saravia","year":"2012","journal-title":"Heart. Fail. Rev."},{"issue":"2","key":"10.1016\/j.actatropica.2025.107940_bib0094","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.molbiopara.2005.12.001","article-title":"Deletion of copies of the gene encoding old yellow enzyme (TcOYE), a NAD(P)H flavin oxidoreductase, associates with in vitro-induced benznidazole resistance in Trypanosoma cruzi","volume":"146","author":"Murta","year":"2006","journal-title":"Mol. Biochem. Parasitol."},{"issue":"6","key":"10.1016\/j.actatropica.2025.107940_bib0095","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1080\/17460441.2024.2349155","article-title":"New drug discovery strategies for the treatment of benznidazole-resistance in Trypanosoma cruzi, the causative agent of Chagas disease","volume":"19","author":"Murta","year":"2024","journal-title":"Expert. Opin. Drug Discov."},{"issue":"1\u20132","key":"10.1016\/j.actatropica.2025.107940_bib0096","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.actatropica.2006.10.004","article-title":"Increased expression of iron-containing superoxide dismutase-A (TcFeSOD-A) enzyme in Trypanosoma cruzi population with in vitro-induced resistance to benznidazole","volume":"100","author":"Nogueira","year":"2006","journal-title":"Acta Trop."},{"issue":"1","key":"10.1016\/j.actatropica.2025.107940_bib0097","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11686-024-00986-w","article-title":"Expression analysis of thirteen genes in response to nifurtimox and benznidazole in Mexican isolates of trypanosoma cruzi by Digital PCR","volume":"70","author":"Ochoa-Mart\u00ednez","year":"2025","journal-title":"Acta Parasitol."},{"issue":"1","key":"10.1016\/j.actatropica.2025.107940_bib0098","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3390\/tropicalmed6010017","article-title":"The cost of lost productivity due to premature Chagas disease-related mortality: lessons from Colombia (2010-2017)","volume":"6","author":"Olivera","year":"2021","journal-title":"Trop. Med. Infect. Dis."},{"issue":"3","key":"10.1016\/j.actatropica.2025.107940_bib0099","first-page":"240","article-title":"Cardiac evaluation in the acute phase of Chagas' Disease with post-treatment evolution in patients attended in the State of Amazonas, Brazil","volume":"112","author":"Ortiz","year":"2019","journal-title":"Arq. Bras. Cardiol."},{"key":"10.1016\/j.actatropica.2025.107940_bib0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpddr.2025.100623","article-title":"Comparative transcriptomics of naturally susceptible and resistant Trypanosoma cruzi strains in response to Benznidazole","volume":"29","author":"Ospina","year":"2025","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"issue":"3","key":"10.1016\/j.actatropica.2025.107940_bib0101","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003583","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"18","author":"Page","year":"2021","journal-title":"PLoS. Med."},{"issue":"3","key":"10.1016\/j.actatropica.2025.107940_bib0102","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/cbdd.14257","article-title":"A comprehensive review on potential candidates for the treatment of chagas disease","volume":"102","author":"Pathak","year":"2023","journal-title":"Chem. Biol. Drug Des."},{"issue":"7","key":"10.1016\/j.actatropica.2025.107940_bib0103","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00069-20","article-title":"Combination therapy using Benznidazole and Aspirin during the acute phase of experimental Chagas disease prevents cardiovascular dysfunction and decreases typical cardiac lesions in the chronic phase","volume":"64","author":"Pereira","year":"2020","journal-title":"Antimicrob. Agents Chemother"},{"issue":"5","key":"10.1016\/j.actatropica.2025.107940_bib0104","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006480","article-title":"Impact of benznidazole treatment on the functional response of Trypanosoma cruzi antigen-specific CD4+CD8+ T cells in chronic Chagas disease patients","volume":"12","author":"P\u00e9rez-Ant\u00f3n","year":"2018","journal-title":"PLoS. Negl. Trop. Dis."},{"issue":"9","key":"10.1016\/j.actatropica.2025.107940_bib0105","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.eimc.2020.04.011","article-title":"Trypanocidal treatment of Chagas disease","volume":"39","author":"P\u00e9rez-Molina","year":"2021","journal-title":"Enferm. Infecc. Microbiol. Clin. (Engl. Ed)"},{"key":"10.1016\/j.actatropica.2025.107940_bib0106","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2019.105161","article-title":"Mapping benznidazole resistance in trypanosomatids and exploring evolutionary histories of nitroreductases and ABCG transporter protein sequences","volume":"200","author":"Petravicius","year":"2019","journal-title":"Acta Trop."},{"issue":"3","key":"10.1016\/j.actatropica.2025.107940_bib0107","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1590\/0037-8682-0433-2016","article-title":"Chagas disease: review of needs, neglect, and obstacles to treatment access in Latin America","volume":"50","author":"Pinheiro","year":"2017","journal-title":"Rev. Soc. Bras. Med. Trop."},{"issue":"4","key":"10.1016\/j.actatropica.2025.107940_bib0108","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/em.21839","article-title":"Unveiling benznidazole's mechanism of action through overexpression of DNA repair proteins in Trypanosoma cruzi","volume":"55","author":"Raj\u00e3o","year":"2014","journal-title":"Environ. Mol. Mutagen."},{"issue":"4","key":"10.1016\/j.actatropica.2025.107940_bib0109","doi-asserted-by":"crossref","first-page":"e2776","DOI":"10.1371\/journal.pntd.0002776","article-title":"Opportunity cost for early treatment of Chagas disease in Mexico","volume":"8","author":"Ramsey","year":"2014","journal-title":"PLoS. Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2025.107940_bib0110","doi-asserted-by":"crossref","first-page":"e899","DOI":"10.1371\/journal.pntd.0000899","article-title":"Chagas cardiomyopathy manifestations and Trypanosoma cruzi genotypes circulating in chronic Chagasic patients","volume":"4","author":"Ram\u00edrez","year":"2010","journal-title":"PLoS. Negl. Trop. Dis."},{"issue":"6","key":"10.1016\/j.actatropica.2025.107940_bib0111","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1590\/0037-8682-0495-2017","article-title":"The continuous challenge of Chagas disease treatment: bridging evidence-based guidelines, access to healthcare, and human rights","volume":"50","author":"Ramos-Junior","year":"2017","journal-title":"Rev. Soc. Bras. Med. Trop."},{"issue":"6","key":"10.1016\/j.actatropica.2025.107940_bib0112","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.4269\/ajtmh.22-0081","article-title":"Knowledge about Chagas Disease among Family and Community medicine residents in a non-endemic region: a cross-sectional study","volume":"108","author":"Ramos-Rinc\u00f3n","year":"2023","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.actatropica.2025.107940_bib0113","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1590\/S1518-8787.2016050005911","article-title":"Community resilience and Chagas disease in a rural region of Mexico","volume":"50","author":"Rangel","year":"2016","journal-title":"Rev. Saude Publica"},{"key":"10.1016\/j.actatropica.2025.107940_bib0114","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.exppara.2014.11.007","article-title":"Molecular characterization of Cyclophilin (TcCyP19) in Trypanosoma cruzi populations susceptible and resistant to benznidazole","volume":"148","author":"R\u00eago","year":"2015","journal-title":"Exp. Parasitol."},{"issue":"4","key":"10.1016\/j.actatropica.2025.107940_bib0115","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00232-016-9888-z","article-title":"Trypanosoma cruzi polyamine transporter: its role on parasite growth and survival under stress conditions","volume":"249","author":"Reigada","year":"2016","journal-title":"J. Membr. Biol."},{"issue":"48","key":"10.1016\/j.actatropica.2025.107940_bib0116","doi-asserted-by":"crossref","first-page":"30566","DOI":"10.1073\/pnas.2009506117","article-title":"Aneuploidy increases resistance to chemotherapeutics by antagonizing cell division","volume":"117","author":"Replogle","year":"2020","journal-title":"Proc. Natl. Acad. Sci. u S. a"},{"issue":"4","key":"10.1016\/j.actatropica.2025.107940_bib0117","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3390\/pathogens8040197","article-title":"Vitro Benznidazole and Nifurtimox susceptibility profile of Trypanosoma cruzi strains belonging to discrete typing units TcI, TcII, and TcV","volume":"8","author":"Revollo","year":"2019","journal-title":"Pathogens."},{"issue":"16","key":"10.1016\/j.actatropica.2025.107940_bib0118","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1042\/BCJ20180232","article-title":"A role for trypanosomatid aldo-keto reductases in methylglyoxal, prostaglandin and isoprostane metabolism","volume":"475","author":"Roberts","year":"2018","journal-title":"Biochem. J."},{"key":"10.1016\/j.actatropica.2025.107940_bib0119","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/978-1-4939-9148-8_13","article-title":"In situ detection of dormant trypanosoma cruzi amastigotes using bioluminescent-fluorescent reporters","volume":"1955","author":"S\u00e1nchez-Vald\u00e9z","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.actatropica.2025.107940_bib0120","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.34039","article-title":"Spontaneous dormancy protects Trypanosoma cruzi during extended drug exposure","volume":"7","author":"S\u00e1nchez-Vald\u00e9z","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.actatropica.2025.107940_bib0121","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/9081813","article-title":"Potential role of antioxidants as adjunctive therapy in Chagas Disease","volume":"2020","author":"S\u00e1nchez-Villamil","year":"2020","journal-title":"Oxid. Med. Cell Longev."},{"issue":"10","key":"10.1016\/j.actatropica.2025.107940_bib0122","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010845","article-title":"Disruption of multiple copies of the prostaglandin F2alpha synthase gene affects oxidative stress response and infectivity in Trypanosoma cruzi","volume":"16","author":"Santi","year":"2022","journal-title":"PLoS. Negl. Trop. Dis."},{"issue":"2","key":"10.1016\/j.actatropica.2025.107940_bib0123","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.molbiopara.2009.05.005","article-title":"The role of ATP-binding cassette (ABC) proteins in protozoan parasites","volume":"167","author":"Sauvage","year":"2009","journal-title":"Mol. Biochem. Parasitol."},{"issue":"3","key":"10.1016\/j.actatropica.2025.107940_bib0124","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0092028","article-title":"Proline modulates the Trypanosoma cruzi resistance to reactive oxygen species and drugs through a novel D, l-proline transporter","volume":"9","author":"Say\u00e9","year":"2014","journal-title":"PLoS. One"},{"issue":"2","key":"10.1016\/j.actatropica.2025.107940_bib0125","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1590\/0037-8682-0337-2017","article-title":"Response to different benznidazole doses in animal models of chronic phase Chagas disease: a critical review","volume":"51","author":"Scarim","year":"2018","journal-title":"Rev. Soc. Bras. Med. Trop."},{"issue":"3\u20134","key":"10.1016\/j.actatropica.2025.107940_bib0126","first-page":"66","article-title":"Algunos datos y observaciones pragm\u00e1ticas en relaci\u00f3n a la epidemiolog\u00eda de la enfermedad de Chagas [Pragmatic data and observations related to the epidemiology of Chagas disease]","volume":"44","author":"Schenone","year":"1989","journal-title":"Bol. Chil. Parasitol."},{"issue":"1\u20132","key":"10.1016\/j.actatropica.2025.107940_bib0127","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.actatropica.2009.11.003","article-title":"Chagas disease: a Latin American health problem becoming a world health problem","volume":"115","author":"Schmunis","year":"2010","journal-title":"Acta Trop."},{"issue":"1","key":"10.1016\/j.actatropica.2025.107940_bib0128","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s12639-021-01418-6","article-title":"Molecular characterization of trypanosoma cruzi DTUs of the triatomine species in a Chagas disease endemic area","volume":"46","author":"Silva","year":"2022","journal-title":"J. Parasit. Dis."},{"key":"10.1016\/j.actatropica.2025.107940_bib0129","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1342431","article-title":"New insights into Trypanosoma cruzi genetic diversity, and its influence on parasite biology and clinical outcomes","volume":"15","author":"Silvestrini","year":"2024","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.actatropica.2025.107940_bib0131","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0012225","article-title":"Oral Chagas disease outbreak by bacaba juice ingestion: a century after Carlos Chagas' discovery, the disease is still hard to manage","volume":"18","author":"Sim\u00f5es-Neto","year":"2024","journal-title":"PLoS. Negl. Trop. Dis."},{"issue":"1","key":"10.1016\/j.actatropica.2025.107940_bib0132","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2020.152046","article-title":"Benznidazole: hero or villain of cellular immune response in chronic Chagas disease patients?","volume":"226","author":"Soares","year":"2021","journal-title":"Immunobiology"},{"issue":"4","key":"10.1016\/j.actatropica.2025.107940_bib0133","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1007\/s13346-024-01664-0","article-title":"Efficacy of a Zn-based metalorganic framework doped with benznidazole on acute experimental Trypanosoma cruzi infection","volume":"15","author":"Sosa-Arroniz","year":"2025","journal-title":"Drug Deliv. Transl. Res."},{"issue":"10","key":"10.1016\/j.actatropica.2025.107940_bib0134","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s11886-024-02113-7","article-title":"Chagas Disease: epidemiology, diagnosis, and treatment","volume":"26","author":"Swett","year":"2024","journal-title":"Curr. Cardiol. Rep."},{"issue":"10","key":"10.1016\/j.actatropica.2025.107940_bib0135","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.molmed.2016.07.008","article-title":"Chagas Disease: a solvable problem, ignored","volume":"22","author":"Tarleton","year":"2016","journal-title":"Trends. Mol. Med."},{"issue":"8","key":"10.1016\/j.actatropica.2025.107940_bib0136","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S1473-3099(20)30844-6","article-title":"New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial","volume":"21","author":"Torrico","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.actatropica.2025.107940_bib0137","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.exppara.2014.03.013","article-title":"Trypanosoma cruzi chemical proteomics using immobilized benznidazole","volume":"140","author":"Trochine","year":"2014","journal-title":"Exp. Parasitol."},{"issue":"1\u20132","key":"10.1016\/j.actatropica.2025.107940_bib0138","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.mam.2004.02.021","article-title":"Oxidative stress and antioxidant defenses: a target for the treatment of diseases caused by parasitic protozoa","volume":"25","author":"Turrens","year":"2004","journal-title":"Mol. Aspects. Med."},{"key":"10.1016\/j.actatropica.2025.107940_bib0139","first-page":"265","volume":"2","author":"Urdaneta-Morales","year":"2014"},{"issue":"2","key":"10.1016\/j.actatropica.2025.107940_bib0141","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3390\/pathogens14020178","article-title":"New approaches to the ecology of triatoma sordida in peridomestic environments of an endemic area of Minas Gerais, Brazil","volume":"14","author":"Valen\u00e7a-Barbosa","year":"2025","journal-title":"Pathogens."},{"key":"10.1016\/j.actatropica.2025.107940_bib0142","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.actatropica.2016.09.010","article-title":"Changes in the immune response after treatment with benznidazole versus no treatment in patients with chronic indeterminate Chagas disease","volume":"164","author":"Vallejo","year":"2016","journal-title":"Acta Trop."},{"issue":"3","key":"10.1016\/j.actatropica.2025.107940_bib0143","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009269","article-title":"In vitro susceptibility of Trypanosoma cruzi discrete typing units (DTUs) to benznidazole: a systematic review and meta-analysis","volume":"15","author":"Vela","year":"2021","journal-title":"PLoS. Negl. Trop. Dis."},{"issue":"1","key":"10.1016\/j.actatropica.2025.107940_bib0144","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41597-022-01452-w","article-title":"Discrete typing units of Trypanosoma cruzi: geographical and biological distribution in the","volume":"9","author":"Vel\u00e1squez-Ortiz","year":"2022","journal-title":"Americas. Sci Data."},{"issue":"7","key":"10.1016\/j.actatropica.2025.107940_bib0145","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1128\/AAC.49.7.2701-2709.2005","article-title":"Differential gene expression in benznidazole-resistant Trypanosoma cruzi parasites","volume":"49","author":"Villarreal","year":"2005","journal-title":"Antimicrob. Agents Chemother"},{"issue":"10","key":"10.1016\/j.actatropica.2025.107940_bib0146","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanmic.2025.101156","article-title":"E1224; BENDITA Study Groups. Quantifying anti-trypanosomal treatment effects in chronic indeterminate Chagas disease: a secondary analysis of individual patient data from two proof-of-concept trials","volume":"6","author":"Watson","year":"2025","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.actatropica.2025.107940_bib0147","series-title":"Chagas Disease (also known as American trypanosomiasis)","year":"2025"},{"issue":"1","key":"10.1016\/j.actatropica.2025.107940_bib0148","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13071-024-06598-7","article-title":"Human migrations, anthropogenic changes, and insect-borne diseases in Latin America","volume":"18","author":"Wilke","year":"2025","journal-title":"Parasit. Vectors."},{"key":"10.1016\/j.actatropica.2025.107940_bib0149","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1042\/bj3520755","article-title":"Biochemical characterization of a trypanosome enzyme with glutathione-dependent peroxidase activity","author":"Wilkinson","year":"2000","journal-title":"Biochem. J."},{"issue":"13","key":"10.1016\/j.actatropica.2025.107940_bib0150","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.1073\/pnas.0711014105","article-title":"A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes","volume":"105","author":"Wilkinson","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U S. A"},{"issue":"Pt 3","key":"10.1016\/j.actatropica.2025.107940_bib0151","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1042\/bj20020038","article-title":"TcGPXII, a glutathione-dependent trypanosoma cruzi peroxidase with substrate specificity restricted to fatty acid and phospholipid hydroperoxides, is localized to the endoplasmic reticulum","volume":"364","author":"Wilkinson","year":"2002","journal-title":"Biochem. J."},{"issue":"3","key":"10.1016\/j.actatropica.2025.107940_bib0152","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1590\/0074-02760140407","article-title":"A novel ABCG-like transporter of Trypanosoma cruzi is involved in natural resistance to benznidazole","volume":"110","author":"Zingales","year":"2015","journal-title":"Mem. Inst. Oswaldo Cruz."},{"key":"10.1016\/j.actatropica.2025.107940_bib0153","doi-asserted-by":"crossref","DOI":"10.1590\/0074-02760210193","article-title":"Trypanosoma cruzi genetic diversity: impact on transmission cycles and Chagas disease","volume":"117","author":"Zingales","year":"2022","journal-title":"Mem. Inst. Oswaldo Cruz."},{"issue":"12","key":"10.1016\/j.actatropica.2025.107940_bib0154","first-page":"2339","article-title":"Fifteen years after the definition of trypanosoma cruzi DTUs: what have we learned?","volume":"13","author":"Zingales","year":"2023","journal-title":"Life (Basel)"},{"issue":"6","key":"10.1016\/j.actatropica.2025.107940_bib0155","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1590\/0074-0276140156","article-title":"Drugs for neglected Disease Initiative; Chagas Clinical Research Platform Meeting. Drug discovery for Chagas disease should consider Trypanosoma cruzi strain diversity","volume":"109","author":"Zingales","year":"2014","journal-title":"Mem. Inst. Oswaldo Cruz."},{"key":"10.1016\/j.actatropica.2025.107940_bib0156","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.actatropica.2017.09.017","article-title":"Trypanosoma cruzi genetic diversity: something new for something known about Chagas disease manifestations, serodiagnosis and drug sensitivity","volume":"184","author":"Zingales","year":"2018","journal-title":"Acta Trop."}],"container-title":["Acta Tropica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X25004097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X25004097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T17:57:06Z","timestamp":1769795826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001706X25004097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":156,"alternative-id":["S0001706X25004097"],"URL":"https:\/\/doi.org\/10.1016\/j.actatropica.2025.107940","relation":{},"ISSN":["0001-706X"],"issn-type":[{"value":"0001-706X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanisms of resistance of Trypanosoma cruzi to benznidazole and nifurtimox: Molecular implications and multifaceted impact","name":"articletitle","label":"Article Title"},{"value":"Acta Tropica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actatropica.2025.107940","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107940"}}